Wag! Group (PET) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
7 Aug, 2025Executive summary
Filed for Chapter 11 bankruptcy on July 21, 2025, with all existing equity interests to be canceled if the reorganization plan is approved.
Revenues declined 10.4% year-over-year for Q2 2025 and 23.8% for the six months ended June 30, 2025.
Net loss increased to $6.1 million for Q2 2025 and $11.0 million for the six months, with negative Adjusted EBITDA.
Delisted from Nasdaq on July 30, 2025; securities now trade on the Pink Open Market.
Sold Furscription software for $5.0 million in July 2025 to pay down debt.
Financial highlights
Q2 2025 revenue: $16.7 million (down from $18.7 million in Q2 2024); six months: $31.9 million (down from $41.9 million year-over-year).
Q2 2025 net loss: $6.1 million (vs. $2.3 million prior year); six months: $11.0 million (vs. $6.5 million prior year).
Adjusted EBITDA loss: $2.2 million for Q2 2025 (vs. $1.6 million gain prior year); margin -13.0%.
Net cash used in operating activities: $1.3 million for six months ended June 30, 2025.
Cash and cash equivalents at June 30, 2025: $2.7 million; total debt: $19.6 million.
Outlook and guidance
Substantial doubt exists about ability to continue as a going concern; future performance depends on bankruptcy court approval and successful restructuring.
Financial results expected to remain volatile until emergence from Chapter 11.
Latest events from Wag! Group
- Record adjusted EBITDA and improved margins achieved, but liquidity and debt risks persist.PET
Q2 20242 Feb 2026 - Q3 revenue fell 39% with deepening losses, but Wellness rebounded and debt reduction continues.PET
Q3 202414 Jan 2026 - Q4 rebounded with 17%+ sequential growth; 2025 revenue guided at $84–$88 million.PET
Q4 202426 Dec 2025 - Q1 2025 revenue fell 34.7%, net loss widened, and liquidity risks persist despite new partnerships.PET
Q1 202527 Nov 2025